Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy.

Lauren A MarcathColin M FinleySiu Fun WongDaniel Louis Hertz

Published in: BMC cancer (2021)

The high DDI prevalence in subjects enrolled on SWOG clinical trials, including a high prevalence that violate trial exclusion criteria, support the need for improved processes for DDI screening to ensure trial subject safety and trial data accuracy.

Keyphrases

clinical trial
phase iii
phase ii
study protocol
risk factors
open label
randomized controlled trial
emergency department
big data
artificial intelligence
drug induced